Drug Cos. Float Deals Worth $50B To End Opioid Cases
Major drug manufacturers and distributors — including Johnson & Johnson and McKesson — are proposing deals that could be worth a combined $50 billion to resolve large portions of nationwide litigation...To view the full article, register now.
Already a subscriber? Click here to view full article